The predictive factors of &#945;1-D/A adrenoceptor antagonist, naftopidil, dose increase therapy for male lower urinary tract symptoms caused by benign prostatic hyperplasia: INFORM study.

Tanuma, Yasushi; Tanaka, Yoshinori; Takeyama, Ko; Okamoto, Tomoshi

The predictive factors of α1-D/A adrenoceptor antagonist, naftopidil, dose increase therapy for male lower urinary tract symptoms caused by benign prostatic hyperplasia: INFORM study.

Tanuma, Yasushi; Tanaka, Yoshinori; Takeyama, Ko; Okamoto, Tomoshi.

Afiliación

Tanuma Y; Department of Urology, Hokkaido Social Welfare Association Hakodate Hospital, Hakodate, Japan.
Tanaka Y; Department of Urology, Hokkaido Prefectural Esashi Hospital, Esashi, Japan.
Takeyama K; Department of Urology, Hakodate National Hospital, Hakodate, Japan.
Okamoto T; Okamoto Urology Clinic, Hokkaido, Japan.

Urol Ann ; 9(3): 261-267, 2017.

Article en En | MEDLINE | ID: mdl-28794594

Palabras clave

Dose increase therapy; lower urinary tract symptoms/benign prostatic hyperplasia; naftopidil; predictive factor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Urol Ann Año: 2017 Tipo del documento: Article País de afiliación: Japón Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google